AMCP-NEXUS 2022: Real-world adherence and persistence to single versus…
The AMCP-NEXUS 2022 National Meeting took place 11–14 October 2022 in National Harbour…
ATS 2022: Randomized study comparing inhaler technique with Ellipta versus Breezhaler
The ATS 2022 International Conference took place 13–18 May 2022 in San Francisco, California, United States, showcasing breakthrough innovations in science and patient care in respiratory and pulmonary fields.
Van der Palen J, et al. presented a poster titled ‘A Randomized, Cross-Over Study Comparing Critical and Overall Errors, Teaching Time, and Preference of the Ellipta Versus Breezhaler Dry Powder Inhalers in Patients with Asthma’.
Please use the link below to view the presented poster.
View this poster in detail
Related materials
Asthma Forward is a registered trade mark of the GSK group of companies.
©2023 GSK group of companies. All rights reserved.
NX-GBL-FVU-WCNT-230005 | March 2023